Market Overview

Alnylam Pharma Reports Offering of $125M in Stock

Related ALNY
Mid-Day Market Update: McDonald's Drops On Weak November Sales; Acceleron Pharma Shares Jump
Mid-Morning Market Update: Markets Mixed; Merck To Buy Cubist Pharmaceuticals For $102/Share
Action in Ebola-Related Stocks (Fox Business)

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading RNAi therapeutics company, today announced that it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $125 million. All of the shares in the offering are to be sold by Alnylam.

Posted-In: News Offerings

 

Related Articles (ALNY)

Around the Web, We're Loving...

Get Benzinga's Newsletters